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Postinflammatory hyperpigmentation after human
cold pain testing
Melissa J. Wolza, Katelyn E. Sadlera, Caela C. Longa, Daniel S. Brennerb, Brian S. Kimc, Robert W. Gereau IVb,
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Abstract
Changes in cold temperature sensitivity are often associated with chronic pain conditions. Progress in understanding the
neurobiological mechanism underlying these changes and resulting development of effective therapies has been slowed by the
accessibility and affordability of devices used to measure thermal sensitivity in humans. To address this gap, we developed an
inexpensive method to measure cold pain thresholds in healthy adult volunteers using dry ice and a thermode. However, early in
preliminary testing, a subject presented with epidermal postinflammatory hyperpigmentation that lasted for .200 days. Although
this responsewas unique among the small number of subjects in development of the assay, it raised questions as to the safety of the
assay design.
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1. Introduction
Increased sensitivity to cold stimuli (eg, ice, cold liquids, etc.) is
a common symptom described by patients with chronic pain.1–5
Identification of cold pain receptors (eg, TRPA1 and TRPM81) in
the last few years has sparked rodent studies on themechanisms
of cold sensation6,7; however, the number of human studies on
cold pain has remained low, in part because of available assay
deficiencies.8
In humans, methods to assess cold sensitivity are limited to
verbal reports of discomfort after cold stimuli application, the cold
pressor test, or use of Peltier thermodes.8 All thesemethods have
one or more limiting factors as follows: verbal reports are not
quantifiable or reproducible between subjects, the cold pressor
test only measures cold pain tolerance and not cold pain
thresholds, and Peltier devices are cost prohibitive for wide
adoption.9,10
Recently, a new cold sensory assay was developed for use in
animals. This assay uses dry ice to consistently cool a limited area
underneath an animal’s foot until a withdrawal response
analogous to those observed in the traditional thermal plantar
assay is observed.7,11,12 We applied a similar approach to allow
for quick and inexpensive measurement of cold sensitivity in
humans. Here, we describe an unintended hyperpigmentation
response that was observed during early pilot testing of this
assay.
2. Methods
The study was performed under approval from the Duquesne
University Institutional Review Board (IRB) (protocol #015-02-11
from 3/19/2015 to 3/18/2018). Case participant gave written
informed consent before enrollment into the study. Exclusion
criteria included history of cardiac, respiratory, neurological, or
musculoskeletal disease, acute or chronic pain conditions,
diabetes, anxiety or depression conditions, being currently
pregnant, and allergy to hot chili pepper, benzocaine, menthol,
or handmoisturizer. Three individuals completed the study before
the postinflammatory hyperpigmentation (PIH) event occurred.
After the adverse event described in this article, the study was
suspended. The primary investigator (BJK) reported this event to
the Duquesne University IRB who subsequently reported the
event to the United StatesOffice of HumanResearch Protections,
Division of Compliance Oversight (10/6/2015).
2.1. Testing Apparatus
This new assay was modeled on the cold plantar assay
developed for use in rodents.11,13 A Plexiglas platform (55.8 3
24.4 cm) was suspended 20.3 cm above the counter surface
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with support bars from a standard shelving unit (Fig. 1A). A 1-cm
hole was drilled into the center of the Plexiglas platform. A 4.5 3
4.5-cm (2.4 mm thick) aluminum square was centered over hole
in Plexiglass and secured in place. A rubber mat (1 mm thick) was
placed on top of Plexiglass covering entire surface except for
a ;1-cm hole that was centered on the aluminum square. The
aluminum square was cooled through application of a packed dry
ice pellet to the underside of the aluminum plate (opposite side
from subject) (Fig. 1B). The dry ice pellet was made as previously
described.11 A low-profile type K thermocouple (1 mm width and
0.5 mm thick; Model FLUKE 54 IIB; Fluke Corporation Everett,
WAwith reported temp accuracy of6 0.05%1 0.3˚C) was taped
in place directly next to the center of the aluminum square. The
thermode was selected to minimize interference of stimulus
presentation and could not be detected through forearm touch
alone. The thermode was used to monitor, in real-time, the
temperature of the interface between the metal and the subject’s
skin. To evaluate the temperature that would be experienced by
a subject during a trial, multiple test trials were completed using
a 25 cm L 3 25 cm W 3 3 cm H Styrofoam block over the
aluminum square with or without the rubber mat in place. The
center of the aluminum plate (application site) cooled the most
rapidly (Fig. 1C).
2.2. Study design (for case subject)
The subject received 2 treatments, 10% menthol cream (CVS
Muscle Rub; CVS Pharmacy, Woonsocket, RI) or 20% topical
benzocaine (Lanacane Maximum Strength Spray; Lanacane,
Reckitt Benckiser, Slough, United Kingdom), in a double-blind
crossover design compared with vehicle (Aveeno daily moistur-
izing lotion for menthol; 24% ethanol in H2O for benzocaine).
Although the data are not presented here, we hypothesized that
menthol (a TRPM8 agonist) would increase cold sensitivity and
that benzocaine (local anesthetic) would decrease cold sensitiv-
ity. Briefly, on each day of the experiment, the subject received 2
rounds of cold testing, each test consisting of one baseline trial
followed by a treatment or vehicle trial per stimulation site.
Stimulation sites were 2.5 cm squares traced on the subject’s
forearm with a marker. Three stimulation sites were spaced 2.5
cm apart from each other and were positioned roughly along the
T1 dermatome on each forearm. The time between individual
trials was 2 minutes, and the experimenter alternated between
the left and right forearm stimulation sites. The total number of
cold tests per stimulation square was 4 (2 per day). After testing
on both days, subject was allowed to wash both forearms.
3. Results
During the development of the cold cutaneous assay (Fig. 1), one
subject experienced an adverse response to cold testing. The
subject was a 26-year-old woman of European descent with
Fitzpatrick scale type III skin coloration, possessing no study
exclusion criteria. The subject had an average withdrawal
temperature of 11.1 6 4.5˚C in the left forearm and 11.8 6
6.9˚C in the right forearm. Initially, the subject experienced normal
responses to cold stimuli (red marks in testing sites) and did not
report any adverse sensitivity after completion of testing.
Although other study participants also reported red skin
discoloration in stimulation sites, these marks typically faded
over the course of one day. Nine days after testing, however, the
case subject presented with 6 crescent-shaped macules of
varying color on both forearms, each one developing around the
site of stimulus application (Fig. 2). The pigmentation areas were
flat. The subject did not report changes in pain sensitivity, touch
sensitivity, itch, or thermal allodynia (eg, from a hot shower),
although no quantitative testing was performed before or during
the development of hyperpigmentation because of IRB-approved
protocol limitations. This pigmentation was diagnosed as PIH by
a board-certified dermatologist (BSK) on clinical examination.
Fifty days after testing, the marks were lighter but still visible. By
Figure 1. Setup of cold sensitivity assay. (A) Photograph showing platform for
testing human subject. Subject’s arm insulated from surface by thin rubber
mat (1 mm thickness) except for stimulus application site (;1 cm circle as
indicated). (B) Photograph showing application of dry ice pellet to the
underside of a 4.5 3 4.5-cm aluminum square (2.4 mm thickness). (C)
Temperature measured at the interface of the aluminum plate and a piece of
styrofoam at various distances from center during dry ice application without
rubber mat on platform. The “1-cm rubber” measurement was made on top of
the rubber mat 1 cm from stimulus center to demonstrate that the skin that is
resting on the rubber mat (.1 cm from stimulus center) is insulated from the
primary cooling effect of the dry ice application. For all trials involving human
subjects, 0oC was defined as the safety cutoff.
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240 days after testing and without any therapeutic interventions,
dark macules had faded to visible but near-normal pigment
macules.
4. Discussion
Here, we report the development of PIH at 6 sites on a subject’s
left and right forearms after cold sensitivity testing. The
hyperpigmentation developed around the stimulus borders
where the skin temperature was several degrees warmer than
that in the center, which we believe was likely ischemic. Our
hypothesis is that the subcutaneous blood flow was likely
increased because of inflammation at these borders, leading to
the curious size and shape of the hyperpigmented macules
(Fig. 2), corresponding to the outer borders of the stimulus.
It is unlikely that the pigmentation is due to skin freezing; an
ultraprecise thermocouple was used to monitor temperature at the
skin surfacewith a 0oC safety cutoff. Because the subject withdrew
her arms at ;11oC, skin freezing is an unlikely explanation for the
skin reaction, although we cannot rule out a potential over-
estimation of the temperature by the thermocouple. Another
subject received the same treatment and similar sensitivity thresh-
olds as the case subject with no adverse events reported (data not
shown). In addition, contact dermatitis induced by the aluminum
plate or treatments/vehiclesmay have inducedPIH. Again,we think
this is unlikely due to the shape of the hyperpigmented regions and
the fact that pigmentation was equally induced on both arms
although each arm received a different treatment/vehicle.
Postinflammatory hyperpigmentation is commonly associated
with acne vulgaris, contact and atopic dermatitis, psoriasis, laser
hair removal, and chemical/thermal burns.14,15 Inflammation
stemming from these conditions results in the local release of
chemical mediators including prostaglandins and leukotrienes,
arachidonic acid metabolites that regulate the activity of
Figure 2. Case example of postinflammatory hyperpigmentation. Case subject reported persistent skin pigmentation that was first noticed 9 days after end of
experiment. Subject showed pigmentation on both the left and right (not shown) forearms on all 3 stimulation sites per arm. Dotted box is centered on the same
stimulation site for photographs taken on days 9, 50, 210, and 240 after the end of the experiment. Dotted box area is enlarged to the right of each image to show
example hyperpigmentation and the gradually lightening of hyperpigmentation with time.
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tyrosinase, the melanocyte-localized enzyme that is responsible
for melanin synthesis.16 The pigmentation in this case was
indicative of either epidermal melanosis where excess melanin is
endocytosed by resident keratinocytes17 or dermal melanosis
where excessmelanin is endocytosed by residentmacrophages.18
Lack of a skin biopsy at the time of diagnosis prevents further
mechanistic clarity for this specific case. Because of increased
basal levels ofmelanin, PIHmore commonly affects individualswith
darker skin tones (ie, skin phototypes III to VI on the Fitzpatrick
scale; typical of individuals of Mediterranean, Middle Eastern, or
African descent)19 than those with lighter skin (ie, skin phototypes
I–II; typical of individuals of European descent).20
Reports suggest that individual variability in melanocyte
inflammatory responses is also likely to determine a person’s
susceptibility to PIH.21 In this report, the affected individual self-
reported having type III skin, citing occasional sunburns and the
ability tomaintain amultimonth tan after prolonged sun exposure.
Anecdotal reports like this could be useful exclusionary state-
ments for individuals who would otherwise be included in future
cold cutaneous assay experiments. The cold cutaneous assay
we presented here still needs to be validated as a reliable,
accurate measure of cold sensitivity. Our intent in this case report
is not to establish this model but instead to serve as a cautionary
tale for future development of similar assays.
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